Phoenix, Arizona, has quietly assembled one of America's most comprehensive bioscience ecosystems — and companies are taking notice.

Why it's important: Cities with strong bioscience sectors weather economic downturns better because health care and medical research remain essential, regardless of market conditions.

• As demand for innovation accelerates, regions that offer complete bioscience ecosystems — not just isolated advantages — are best positioned to lead.

Okay, but: Bioscience companies need access to research partnerships, clinical trial capabilities, regulatory expertise, a qualified workforce and sustainable costs.

Traditional coastal markets excel in some areas but struggle to provide the complete package companies need for long-term growth.

• While established bioscience hubs like Boston and San Francisco deal with rising costs and limited space, Phoenix has built the infrastructure needed to capture the next wave of industry growth.

The Valley has steadily built an ecosystem of world-class research, health care facilities and bioscience companies to attract talent and investment from across the globe.

Some examples:

🔎Research powerhouses: The Phoenix Bioscience ecosystem includes:

• Translational Genomic Research Institute (TGen) — Part of City of Hope.
• Barrow Neurological Institute at Phoenix Children's Hospital.
• Dignity Health Barrow Neurological Institute.
• International Genomics Consortium.
• and NIH National Institute of Diabetes and Digestive and Kidney Disorders.

🏥Healthcare excellence: Major healthcare systems like Mayo Clinic's Discovery Oasis campus and Banner Health provide both clinical expertise and research collaboration opportunities.

💼Talent pipeline: Arizona State University, one of the largest and most innovative universities in the U.S., feeds talent directly into the local bioscience sector.

Take note: Market dynamics increasingly favor locations that can provide complete support systems rather than just individual advantages.

• By addressing multiple business needs at once, Phoenix has assembled the building blocks for success through strategic partnerships and infrastructure investments.

Here's how: Phoenix offers bioscience companies advantages that translate to real business benefits while maintaining access to world-class research and clinical capabilities.

• Competitive real estate costs and business-friendly policies make Phoenix attractive for both startups and established companies.

• Innovation support through business incubators like Phoenix Forge, the Center for Entrepreneurial Innovation (CEI) and LabForce.
• A skilled workforce pipeline through partnerships between educational institutions and businesses.

The result: Phoenix's bioscience investments are yielding large-scale economic growth.

• Between 2019 and 2025, more than 14,000 bioscience and health care jobs were created in the city of Phoenix.
• The city also saw more than $6.7 billion in bioscience and health care investments during that same period.

Plus, plus, plus: Phoenix also offers something many other markets cannot — quality of life.

• Lower cost of living, year-round outdoor recreation, cultural attractions, family-friendly communities and affordable housing help companies attract and keep talent.

The takeaway: Phoenix is positioned to capture the next wave of bioscience growth as the industry continues to expand beyond traditional coastal hubs.

• The city leveraged strategic anchors to build something bigger than the sum of its parts.

Learn why Phoenix is the right city for your bioscience company.